UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549


FORM 8-K


CURRENT REPORT


Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934


January 18, 2017

Date of Report (Date of earliest event reported)


WRAPmail, Inc.

(Exact name of registrant as specified in its charter)


Florida

 

____333-208293_______

 

20-3624118

(State or other jurisdiction of incorporation)

 

(Commission File Number)

 

(IRS Employer Identification No.


445 NE 12th Ave. Fort Lauderdale, Florida

 

33301

(Address of principal executive offices)

 

(Zip Code)


Registrant’s telephone number, including area code 516-205-4751



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨

Written communications pursuant to Rule 425 under Securities Act (17 CFR 230.425)

¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




1




1.02 Termination of a Material Definitive Agreement


On April 18, 2017, WRAPmail, Inc (WRAP) terminated its joint venture agreement (the Agreement) with Health Max Group, Inc. (Health Max), which Agreement was disclosed in the Companys current report filed January 17, 2017. The termination was by mutual agreement of the parties following the Companys termination of its acquisition of Health Max.  




2




SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 

WRAPmail,  INC.

 

 

 

 

 

Date: April 21, 2017

By:

___/s/ Marco Alfonsi________

Marco Alfonsi, CEO

 

 

 

 





3